11 November 2024
Celebright Hospital Team Meets with Delegation of Shenzhen Municipal Health Commission

On 15th November 2024, a delegation from Shenzhen Municipal Health Commission visited the newly opened Shanghai Celebright Plastic Surgery Hospital. The two sides held discussions on the innovative layout of Luye Medical’s “body-mind-beauty” development roadmap and its strategic layout in Shenzhen, and the clustering development of Shenzhen’s biomedicine industry, hoping to achieve coordinated development in the future.

Wilson Liu, Vice President of Discipline Development of Luye Medical Group and Executive Dean of Celebright Plastic Surgery Hospital, led everyone to visit the hospital and gave a detailed introduction. The leaders of Shenzhen Municipal Health Commission expressed great affirmation and appreciation for the design of space and specialties and business philosophy of the hospital.

In the subsequent discussion, the two sides exchanged their respective development status, experience and advantages, and future plans in the field of medical and health services, and agreed to jointly explore cooperation opportunities to create a win-win situation in Shenzhen, the modern, international city of innovation.

Chen Jinzhong, Chief Representative of Luye Life Sciences Group in the Greater Bay Area, introduced the development of Luye Life Sciences Group’s biomedical sector in Shenzhen, and said that Luye Medical Group will combine the current “body-mind-beauty” big health industry planning and Shenzhen’s needs to plan its future business, strive for steady development, and promote mutual strength with Shenzhen.

On behalf of Luye Medical Group, Group CEO Charles Wang and Willie Ding, Executive Assistant to The Executive Chairperson of Luye Medical Group and Vice President of Mindfront Health, warmly welcomed the delegation. Charles Wang said: While Shenzhen implements healthcare reform and takes steps to build a high-quality and efficient hospitals network, Luye Medical Group provides the public with diversified innovative medical solutions. Looking ahead, we will remain committed to fostering high-quality medical.